141 related articles for article (PubMed ID: 3160962)
1. Pituitary secretion of growth hormone in response to opioid peptides and opiates is mediated through growth hormone-releasing factor.
Wehrenberg WB; Bloch B; Ling N
Neuroendocrinology; 1985 Jul; 41(1):13-6. PubMed ID: 3160962
[TBL] [Abstract][Full Text] [Related]
2. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
Painson JC; Tannenbaum GS
Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
[TBL] [Abstract][Full Text] [Related]
3. Galanin stimulates growth hormone (GH) secretion via GH-releasing factor (GRF) in conscious rats.
Murakami Y; Kato Y; Koshiyama H; Inoue T; Yanaihara N; Imura H
Eur J Pharmacol; 1987 Apr; 136(3):415-8. PubMed ID: 2440700
[TBL] [Abstract][Full Text] [Related]
4. Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons.
Ganzetti I; Petraglia F; Capuano I; Rosi F; Wehrenberg WB; Müller EE; Cocchi D
J Endocrinol Invest; 1987 Jun; 10(3):241-6. PubMed ID: 2957419
[TBL] [Abstract][Full Text] [Related]
5. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
Lam KS; Reichlin S
Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
[TBL] [Abstract][Full Text] [Related]
6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
Lengyel AM; Tannenbaum GS
Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and prolactin secretion in cultured somatomammotroph cells.
Kashio Y; Chomczynski P; Downs TR; Frohman LA
Endocrinology; 1990 Sep; 127(3):1129-35. PubMed ID: 1974845
[TBL] [Abstract][Full Text] [Related]
9. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
Soya H; Suzuki M
Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
[TBL] [Abstract][Full Text] [Related]
10. Effect of estrogen on the growth hormone (GH) secretory response to GH-releasing factor in the castrate adult female rat in vivo.
Shulman DI; Sweetland M; Duckett G; Root AW
Endocrinology; 1987 Mar; 120(3):1047-51. PubMed ID: 3100282
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat.
Locatelli V; Grilli R; Torsello A; Cella SG; Wehrenberg WB; Müller EE
Pediatr Res; 1994 Aug; 36(2):169-74. PubMed ID: 7970930
[TBL] [Abstract][Full Text] [Related]
12. Opioid control of growth hormone in the suckled sow is primarily mediated through growth hormone releasing factor.
Armstrong JD; Esbenshade KL; Coffey MT; Heimer E; Campbell R; Mowles T; Felix A
Domest Anim Endocrinol; 1990 Apr; 7(2):191-8. PubMed ID: 2114957
[TBL] [Abstract][Full Text] [Related]
13. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.
Tannenbaum GS; Ling N
Endocrinology; 1984 Nov; 115(5):1952-7. PubMed ID: 6149116
[TBL] [Abstract][Full Text] [Related]
14. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
15. Influence of endogenous growth hormone-releasing factor (GRF) on the secretion of GH during the perinatal period in the rat.
Guillaume V; Boudouresque F; Grino M; Dutour A; Peyre G; Tonon MC; Vaudry H; Rougeot C; Conte-Devolx B; Oliver C
Peptides; 1986; 7(3):393-6. PubMed ID: 3095799
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of growth hormone and prolactin release from rat pituitary cell aggregates by bombesin- and ranatensin-like peptides is potentiated by estradiol, 5 alpha-dihydrotestosterone, and dexamethasone.
Houben H; Denef C
Endocrinology; 1990 May; 126(5):2257-66. PubMed ID: 2328688
[TBL] [Abstract][Full Text] [Related]
17. Pituitaries transplanted under the renal capsule contain functional growth hormone (GH) secretors and suppress GH and prolactin release from individual eutopic pituitary cells.
Porter TE; Chen TT; Frawley LS
Endocrinology; 1989 Dec; 125(6):3059-67. PubMed ID: 2510989
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) secretion in the pituitary-grafted male rat: in vivo effects of GH-releasing hormone and isoproterenol and in vitro release by individual somatotropes.
Krieg RJ; Johnson JH; Adler RA
Endocrinology; 1989 Nov; 125(5):2273-8. PubMed ID: 2507290
[TBL] [Abstract][Full Text] [Related]
19. The beta-endorphin-induced secretion of growth hormone but not of prolactin is inhibited by an endogenous opioid antagonist.
Collado-Escobar D; Rovati LC; Ganzetti I; Cocchi D; Panerai AE; Li CH
Eur J Pharmacol; 1986 Oct; 129(3):385-7. PubMed ID: 2946593
[TBL] [Abstract][Full Text] [Related]
20. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
Cheng K; Chan WW; Barreto A; Convey EM; Smith RG
Endocrinology; 1989 Jun; 124(6):2791-8. PubMed ID: 2541999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
